Home About

HALOETTE

ETONOGESTREL AND ETHINYL ESTRADIOL

Manufacturer: Mayne Pharma Inc.

Score: 141.0

Quick Summary

Etonogestrel/Ethinyl Estradiol Vaginal Ring is a combination hormonal contraceptive used to prevent pregnancy in females of reproductive age. The ring is inserted into the vagina and releases etonogestrel and ethinyl estradiol over a three-week period. Key clinical findings indicate that the ring is effective in preventing pregnancy, with a low risk of adverse reactions. However, important safety information and contraindications should be considered, including the risk of serious cardiovascular events, liver disease, and hypersensitivity reactions. The main dosing recommendation is to insert one ring into the vagina and leave it in place for three weeks, followed by a one-week ring-free interval. Special population considerations include use during pregnancy, pediatric use, and geriatric use.

Key Clinical Findings and Indications

  • Prevention of pregnancy in females of reproductive age
  • Effective in preventing pregnancy with a low risk of adverse reactions
  • Combination hormonal contraceptive

Important Safety Information

Warning

Cigarette smoking increases the risk of serious cardiovascular events from combination hormonal contraceptive use

Contraindications

  • High risk of arterial or venous thrombotic diseases
  • Liver tumors, benign or malignant or liver disease
  • Undiagnosed abnormal uterine bleeding
  • Pregnancy
  • Hypersensitivity reactions, including anaphylaxis and angioedema

Adverse Reactions

  • Irregular uterine bleeding
  • Nausea
  • Breast tenderness
  • Headache
  • Vaginitis
  • Mood changes
  • Device-related events

Dosing Recommendations

General Guidance

No dose adjustments are necessary for this medication

Prevention of pregnancy

Adult Dose

One ring inserted into the vagina for three weeks, followed by a one-week ring-free interval

Pediatric Dose

Special Population Considerations

Pregnancy

  • Etonogestrel/Ethinyl Estradiol Vaginal Ring is contraindicated during pregnancy
  • No adverse developmental outcomes were observed in pregnant rats and rabbits with the administration of etonogestrel during organogenesis

Nursing Mothers

  • Advise women who are breastfeeding not to use Etonogestrel/Ethinyl Estradiol Vaginal Ring

Pediatric Use

  • Safety and efficacy of Etonogestrel/Ethinyl Estradiol Vaginal Ring have been established in women of reproductive age
  • Use of this product before menarche is not indicated

Geriatric Use

  • Etonogestrel/Ethinyl Estradiol Vaginal Ring has not been studied in postmenopausal women and is not indicated in this population